An NHS-Funded Tariff Truce
The US-UK pharmaceutical agreement was marketed as a defence against trade threats from Donald Trump. New analysis suggests the health service, not the Treasury, will carry the cost, and the political bill may prove just as heavy.
By
Distilled Post Editorial Team